2% Salicylic Acid
Generic Name: 2% salicylic acid
Brand Names:
Equate 2% Salicylic Acid Acne Treatment Pad
Acne medication
Overview
Acne medication
Uses
Use for the treatment of acne
Dosage
Directions Clean the skin thorougly before applying this product wipe a pad over the face and neck to cover the entire affected area with a thin layer one to three times daily because excessive drying of the skinmay occur, start with oneapplication daily, then gradually increase to two or three times daily if needed or as directd by a doctor. if bothersome dryness or peelingoccur, reduce application to once a day or every other day
Side Effects
avoid contact with the eyes. If product gets into the eyes rinse thoroughly with water. skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. limit use to the face and neck Stop use and ask a doctor if skin or eye irritation develops.
Warnings
For external use only
Frequently Asked Questions
What is 2% Salicylic Acid used for?▼
Use for the treatment of acne
What are the side effects of 2% Salicylic Acid?▼
avoid contact with the eyes. If product gets into the eyes rinse thoroughly with water. skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. limit use to the face and neck Stop use and ask a doctor if skin or eye irritation develops.
What are the important warnings for 2% Salicylic Acid?▼
For external use only
Related Medications
Men Plus Care Stain Defense Clean 72h Antiperspirant
men plus care stain defense clean 72h antiperspirant
Purpose antiperspirant
Antifungal Miconazole Powder Spray
antifungal miconazole powder spray
Purpose Antifungal
Belatacept
belatacept
Selective T Cell Costimulation Blocker [EPC]
11 DESCRIPTION NULOJIX ® (belatacept), a selective T cell costimulation blocker, is a soluble fusion protein consisting of the modified extracellular domain of CTLA-4 fused to a portion (hinge-CH2-CH3 domains) of the Fc domain of a human immunoglobulin G1 antibody. Belatacept is produced by recombinant DNA technology in a mammalian cell expression system. Two amino acid substitutions (L104 to E; A29 to Y) were made in the ligand binding region of CTLA-4.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.